Antibody-mediated inhibition of Bordetella pertussis adenylate cyclase–haemolysin-induced macrophage cytotoxicity is influenced by variations in the bacterial population
Whooping cough is a vaccine-preventable disease presenting with epidemic cycles linked to natural and/or vaccine-driven evolution of the aetiological agent of the disease, Bordetella pertussis. Adenylate cyclase–haemolysin (AC-Hly) is a major toxin produced by this pathogen, which mediates macrophage apoptosis in vitro and in vivo. While current acellular pertussis vaccine (APV) formulations do not include AC-Hly, they all contain pertussis toxin and can comprise filamentous haemagglutinin (FHA), which interacts with AC-Hly, and pertactin (PRN), which has been hypothesized also to interact with AC-Hly. We aimed to study the capacity of specific antibodies to inhibit the in vitro B. pertussis AC-Hly-mediated cytotoxicity of J774A.1 murine macrophages in a background of a changing bacterial population. We demonstrate that: (i) clinical isolates of different types or PRN phenotype are all cytotoxic and lethal in the mouse model of respiratory infection; (ii) lack of PRN production does not impact AC-Hly-related phenotypes; (iii) anti-AC-Hly antibodies inhibit cell lysis whatever the phenotype of the isolate, while anti-PRN antibodies significantly inhibit cell lysis provided the isolate produces this antigen, which might be relevant in vivo for APV-induced immunity; and (iv) anti-FHA antibodies only inhibit lysis induced by isolates collected in 2012, maybe indicating specific characteristics of epidemic lineages of B. pertussis.
AdvaniA.,
Van der HeideH. G.,
HallanderH. O.,
MooiF. R.(2009). Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage. J Microbiol Methods 78:297–301 [View Article][PubMed]
BaronS.,
NjamkepoE.,
GrimprelE.,
BegueP.,
DesenclosJ. C.,
DruckerJ.,
GuisoN.(1998). Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr Infect Dis J 17:412–418 [View Article][PubMed]
BetsouF.,
SeboP.,
GuisoN.(1993). CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase–hemolysin. Infect Immun 61:3583–3589[PubMed]
BonmarinI.,
Levy-BruhlD.,
BaronS.,
GuisoN.,
NjamkepoE.,
CaroV.Renacoq(2007). Pertussis surveillance in French hospitals: results from a 10 year period. Euro Surveill 12:678[PubMed]
BouchezV.,
CaroV.,
LevillainE.,
GuigonG.,
GuisoN.(2008). Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. PLoS ONE 3:e2437 [View Article][PubMed]
BouchezV.,
BrunD.,
CantinelliT.,
DoreG.,
NjamkepoE.,
GuisoN.(2009). First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin. Vaccine 27:6034–6041 [View Article][PubMed]
CarbonettiN. H.,
ArtamonovaG. V.,
AndreasenC.,
BusharN.(2005). Pertussis toxin and adenylate cyclase toxin provide a one–two punch for establishment of Bordetella pertussis infection of the respiratory tract. Infect Immun 73:2698–2703 [View Article][PubMed]
CaroV.,
NjamkepoE.,
Van AmersfoorthS. C.,
MooiF. R.,
AdvaniA.,
HallanderH. O.,
HeQ.,
MertsolaJ.,
RiffelmannM.& other authors (2005). Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect 7:976–982 [View Article][PubMed]
Chenal-FrancisqueV.,
CaroV.,
Boursaux-EudeC.,
GuisoN.(2009). Genomic analysis of the adenylate cyclase–hemolysin C-terminal region of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Res Microbiol 160:330–336 [View Article][PubMed]
CherryJ. D.,
TanT.,
Wirsing von KönigC. H.,
ForsythK. D.,
ThisyakornU.,
GreenbergD.,
JohnsonD.,
MarchantC.,
PlotkinS.(2012). Clinical definitions of pertussis: summary of a Global Pertussis Initiative Roundtable Meeting, February 2011. Clin Infect Dis 54:1756–1764 [View Article][PubMed]
GueirardP.,
DruilheA.,
PretolaniM.,
GuisoN.(1998). Role of adenylate cyclase–hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo. Infect Immun 66:1718–1725[PubMed]
HegerleN.,
RayatL.,
DoreG.,
ZidaneN.,
BedouelleH.,
GuisoN.(2013).In-vitro and in-vivo analysis of the production of the Bordetella type three secretion system effector A in Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Microbes Infect 15:399–408 [View Article][PubMed]
HesterS. E.,
LuiM.,
NicholsonT.,
NowackiD.,
HarvillE. T.(2012). Identification of a CO2 responsive regulon in Bordetella. PLoS ONE 7:e47635 [View Article][PubMed]
KhelefN.,
SakamotoH.,
GuisoN.(1992). Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection. Microb Pathog 12:227–235 [View Article][PubMed]
KhelefN.,
ZychlinskyA.,
GuisoN.(1993).Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase–hemolysin. Infect Immun 61:4064–4071[PubMed]
KhelefN.,
BacheletC. M.,
VargaftigB. B.,
GuisoN.(1994). Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins. Infect Immun 62:2893–2900[PubMed]
MattooS.,
CherryJ. D.(2005). Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18:326–382 [View Article][PubMed]
MiyajiY.,
OtsukaN.,
Toyoizumi-AjisakaH.,
ShibayamaK.,
KamachiK.(2013). Genetic analysis of isolates from the 2008–2010 pertussis epidemic in Japan. PLoS ONE 8:e77165 [View Article][PubMed]
MooiF. R.,
HallanderH.,
Wirsing von KönigC. H.,
HoetB.,
GuisoN.(2000). Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis 19:174–181 [View Article][PubMed]
MooiF. R.,
van LooI. H.,
van GentM.,
HeQ.,
BartM. J.,
HeuvelmanK. J.,
de GreeffS. C.,
DiavatopoulosD.,
TeunisP.& other authors (2009).Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 15:1206–1213 [View Article][PubMed]
MooiF. R.,
VAN DER MaasN. A. T.,
De MelkerH. E.(2014). Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin. Epidemiol Infect 142:685–694 [View Article][PubMed]
PawloskiL. C.,
QueenanA. M.,
CassidayP. K.,
LynchA. S.,
HarrisonM. J.,
ShangW.,
WilliamsM. M.,
BowdenK. E.,
Burgos-RiveraB.& other authors (2014). Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol 21:119–125 [View Article][PubMed]
QueenanA. M.,
CassidayP. K.,
EvangelistaA.(2013). Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med 368:583–584 [View Article][PubMed]
QuinlanT.,
MusserK. A.,
CurrentiS. A.,
ZanskyS. M.,
HalseT. A.(2013). Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004–2013. Mol Cell Probes [View Article][PubMed]
WeberC.,
Boursaux-EudeC.,
CoralieG.,
CaroV.,
GuisoN.(2001). Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J Clin Microbiol 39:4396–4403 [View Article][PubMed]
ZaretzkyF. R.,
GrayM. C.,
HewlettE. L.(2002). Mechanism of association of adenylate cyclase toxin with the surface of Bordetella pertussis: a role for toxin-filamentous haemagglutinin interaction. Mol Microbiol 45:1589–1598 [View Article][PubMed]
Antibody-mediated inhibition of Bordetella pertussis adenylate cyclase–haemolysin-induced macrophage cytotoxicity is influenced by variations in the bacterial population